U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Center for Drug Evaluation and Research

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Impact of Regulations on 
Data Management Practice

11/5/2002

Click here to start


Table of Contents

Impact of Regulations on Data Management Practice

Overview

What is Part 11?

What is Part 11?

PPT Slide

PPT Slide

Part 11 Compliance Committee

Part 11 Compliance Committee

FDA Investigator Training

Inspections

Enforcement Approach

Current Part 11 “Guidance”

Preamble

Compliance Policy Guide

Draft Guidance Documents

FDA Part 11 Compliance Sites

PPT Slide

Part 11 Electronic Submissions

What Submissions Are Currently Accepted in Electronic Format?

What Electronic Submissions Are Being Considered?

Electronic Submission Information

Data Standards

Health Insurance Portability and Accountability Act (HIPAA)

Ingredient and Drug Codes

PPT Slide

Study Data Standards

Standards Development Organizations

Study Data Standards Initiatives

Study Data Information Model

Standard Descriptive Variables

Observations Characterized Using Standard Descriptive Variables

Dataset Structure

Study Data Standards Controlled Terminology

Study Data Standards Data Content Standards

Transmitting and Using Data Current Process

PPT Slide

Information

Author:
Randy Levin, M.D.
Associate Director for Information Management
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Home Page: http://www.fda.gov/cder/regulatory/ersr/default.htm

Download presentation source


totop.gif (1525 bytes) Back to Top   Back Back to ERSR

FDA/Center for Drug Evaluation and Research
Last Updated: November 14, 2002
Originator: OTCOM/DLIS
HTML by SJW